Delivery Order SPE2DB20D1004-SPE2DB23FG5J9
- Not listed
- This federal contract award, valued at $8,091.93, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of Janumet 50-1,000 mg tablets, a medication used to manage diabetes. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, which is valued at up to $999,999,999.00 and runs through November 2026. This larger IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,524.70 delivery order contract is for the procurement of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and a period of performance through May 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This federal contract award, valued at $17,090.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order for the provision of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 7, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established...
- This federal contract award, valued at $11,854.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is September 19, 2023. The contract award does not have a set-aside designation, indicating it was awarded through full and...
- This federal contract award, valued at $13,001.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. This is a firm fixed-price delivery order contract with a completion date of December 29, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for...
- This federal contract award is a delivery order valued at $4,581.31 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award, valued at $9,216.43, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,916.54 delivery order contract is for the supply of JANUMET 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract has a firm fixed price and an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds...
- This federal contract award, valued at $1,848.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract is a delivery order, with a firm fixed price and an ultimate completion date of April 24, 2025. It is not designated as a set-aside contract, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,316.80 firm-fixed-price delivery order is for the supply of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as AmerisourceBergen), valued at up to...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FG5J9Delivery Order
This federal contract award, valued at $1,325.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Janumet 50-1,000 mg Tablets, a medication used to treat type 2 diabetes. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed is a delivery order placed under this IDC. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/11/23 |